How one pharmaceutical company is reinventing the clinical trial

How one pharmaceutical company is reinventing the clinical trial

M illions of Americans— most of us, in fact — rely on medications, from prescription drugs for high cholesterol, diabetes, asthma, cancer, and the like to over-the-counter medicines for allergy, acne, and other conditions. While the myriad medications we take differ from one another, they have something important in common: Before they were sold to […]

Finding Clinical Trials in Cancer

Finding Clinical Trials in Cancer

Conducting clinical trials is critical to the development of new anticancer drugs. These trials are required for the US Food and Drug Administration (FDA) approval of new drugs or indications. Clinical trials also afford patients access to experimental drugs, which could provide a benefit that the patient might not otherwise experience with currently approved agents. […]

FDA Requests Another Clinical Trial for Ruconest in HAE Prophylaxis

FDA Requests Another Clinical Trial for Ruconest in HAE Prophylaxis

The Agency have requested an additional clinical trial to further evaluate the treatments effectiveness as a prophylaxis. The Food and Drug Administration has issued a Complete Response Letter (CRL) to Pharming regarding the supplemental Biologics License Application (sBLA) for Ruconest (C1 esterase inhibitor [recombinant]) to expand the indication to include prophylaxis in patients with hereditary angioedema (HAE).  […]

Equillium Plans IPO to Fund Clinical Trials for Transplant Drug

Equillium Plans IPO to Fund Clinical Trials for Transplant Drug

Xconomy San Diego —  Equillium, a biotech startup developing treatments for immune system disorders—including an immune response that affects some transplant recipients—is preparing for an IPO to finance tests of its lead drug. The company set a preliminary IPO target of $86 million, according to documents filed this week with securities regulators, and has applied […]

Feds target misuse of database on clinical trials by stem cell firms, others

Feds target misuse of database on clinical trials by stem cell firms, others

Federal authorities unveiled plans Thursday to clamp down on misuse of a government-run database of clinical trials that for-profit clinics — many of them selling unproven stem cell therapies — use as a marketing tool to draw customers. The database, ClinicalTrials.gov, is a massive clearinghouse for research studies, most of them testing the safety or […]

Cannabics Pharmaceuticals to Present Results of Clinical Trial at International Medical Cannabis Conference

Cannabics Pharmaceuticals to Present Results of Clinical Trial at International Medical Cannabis Conference

TEL AVIV, Israel and BETHESDA, Maryland, Sept. 21, 2018 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on Cancer and its side effects, today announced that Dr. Gil Bar-Sela is scheduled to present his findings at the 3rd International Medical Cannabis Conference. This Conference is held for global leaders in areas of […]

Barrow Researchers deploy novel clinical trial regimen for glioblastoma

Barrow Researchers deploy novel clinical trial regimen for glioblastoma

(PHOENIX – Sept. 21, 2018) Combating glioblastoma remains a major challenge due the complex nature of these tumors, the inability of drugs to penetrate the brain tissue, and lack of correlation between animal models and the human condition. In a novel first-in-human phase 0 clinical trial study led by Dr. Nader Sanai at Barrow Neurological […]

Oxurion enrolls first patient in clinical trial evaluating DME therapy

Oxurion enrolls first patient in clinical trial evaluating DME therapy

Healio Ophthalmology Retina/Vitreous September 21, 2018 Add Topic To Email Alerts ‘); $j(‘.topic-alert-section .dropdown-menu .auth’).hide(); $j(‘.topic-alert-section .dropdown-menu .anon’).hide(); $j(‘.topic-alert-section .dropdown-menu .subscribed’).show(); $j(‘.topic-alert-section .dropdown-menu’).removeClass(‘anon-dropdown’); $j(‘.topic-alert-section .dropdown-menu’).addClass(‘subscribed-dropdown’); $j(“.manage-alerts”).show(); } function TopicListAddSuccess() { $j(“.topic-alert-section”).removeClass(“open”); ShowAddedToAlerts(); AlertMemberAddedToList($j(“.dropdown-topic”).html().trim()); } function AddEmailToTopicList(button) { $j.fn.validator.Constructor.FOCUS_OFFSET = “0px”; $j(“.topic-alert-section”).validator(“validate”); […]